Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Xiamen Amoytop Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	284.9	412.96	301.24	285.42	197.16	205.89
Trading Asset Securities	139.87	257.08	270.78	196.38	268.22	-
Cash & Short-Term Investments	424.77	670.04	572.02	481.8	465.38	205.89
Cash Growth	22.23%	17.14%	18.73%	3.53%	126.04%	41.93%
Accounts Receivable	531.7	441.02	223.05	206.28	185	141.25
Other Receivables	31.77	17.87	20.17	21.67	11.99	15.39
Receivables	563.47	458.9	243.22	227.94	196.99	156.64
Inventory	230.11	187.02	129.73	116.49	99.62	70.6
Other Current Assets	65.3	24.24	10.64	8.19	10.81	12.08
Total Current Assets	1,284	1,340	955.61	834.42	772.8	445.2
Property, Plant & Equipment	586.63	490.85	389.77	192.92	126.74	96.22
Other Intangible Assets	173.83	191.54	121.69	146.91	172.28	196.41
Long-Term Deferred Tax Assets	43.88	43.66	47.18	34.96	24.97	23.41
Long-Term Deferred Charges	202.54	176.7	229.25	169.14	78.24	23.5
Other Long-Term Assets	114.05	112.98	26.05	44.99	16.24	3.24
Total Assets	2,405	2,356	1,770	1,424	1,193	789.83
Accounts Payable	28.97	39.73	50.91	8.14	7.15	10.09
Accrued Expenses	174.46	244.46	159.55	120.4	60.94	51.74
Short-Term Debt	-	-	-	10	18.92	60.09
Current Portion of Leases	4.33	4.16	4.18	5.79	-	-
Current Income Taxes Payable	29.15	48.95	41.97	24.42	8.73	19.24
Current Unearned Revenue	68.74	60.05	7.23	5.18	3.34	6.6
Other Current Liabilities	9.37	6.31	4.05	3.3	15.86	2.97
Total Current Liabilities	315.02	403.66	267.89	177.23	114.94	150.72
Long-Term Leases	5.87	3.76	5.56	9.37	-	-
Long-Term Unearned Revenue	37.57	40.62	47.68	51.25	56.84	60.3
Long-Term Deferred Tax Liabilities	0.55	0.41	15.15	5.54	3.07	1.42
Other Long-Term Liabilities	31.78	31.25	25.99	19.53	17.48	13.83
Total Liabilities	390.79	479.69	362.27	262.91	192.33	226.27
Common Stock	406.8	406.8	406.8	406.8	406.8	360.3
Additional Paid-In Capital	397.04	397.04	397.04	397.04	397.04	113.09
Retained Earnings	1,210	1,073	603.76	357.42	196.56	90.16
Shareholders' Equity	2,014	1,876	1,408	1,161	1,000	563.55
Total Liabilities & Equity	2,405	2,356	1,770	1,424	1,193	789.83
Total Debt	10.2	7.92	9.74	25.16	18.92	60.09
Net Cash (Debt)	414.57	662.11	562.28	456.63	446.46	145.79
Net Cash Growth	23.14%	17.76%	23.14%	2.28%	206.23%	94.23%
Net Cash Per Share	1.02	1.63	1.39	1.13	1.11	0.41
Filing Date Shares Outstanding	406.8	406.8	406.8	406.8	406.8	406.8
Total Common Shares Outstanding	406.8	406.8	406.8	406.8	406.8	360.3
Working Capital	968.64	936.53	687.72	657.19	657.86	294.48
Book Value Per Share	4.95	4.61	3.46	2.85	2.46	1.56
Tangible Book Value	1,840	1,685	1,286	1,014	828.12	367.15
Tangible Book Value Per Share	4.52	4.14	3.16	2.49	2.04	1.02
Buildings	135.53	135.53	118.65	21.31	22.03	24.62
Machinery	351.77	319.97	271.83	177.83	173.49	162.21
Construction In Progress	259.97	183.72	135.81	118	68.43	37.21

Source: S&P Capital IQ. Standard template. Financial Sources.